Aciclovir/hydrocortisone cream - Medivir

Drug Profile

Aciclovir/hydrocortisone cream - Medivir

Alternative Names: Acyclovir/hydrocortisone; Lipsovir®; ME-609; Xerclear; Xerese

Latest Information Update: 19 Aug 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator AstraZeneca; Medivir AB
  • Developer Daewoong Pharmaceutical; Meda; Medivir AB
  • Class Anti-inflammatories; Antiallergics; Antivirals; Glucocorticoids; Hypoxanthines; Nucleosides; Pregnenediones; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Herpes labialis

Most Recent Events

  • 05 Aug 2016 Meda has been acquired by Mylan
  • 31 Jan 2014 Launched for Herpes labialis (In children) in USA (Topical)
  • 31 Jan 2014 Registered for Herpes labialis (In children) in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top